Clinical trials: Transplant, Liver
Intrahepatic Cholangiocarcinoma
Liver Transplantation for Non-Resectable Intrahepatic Cholangiocarcinoma: a Prospective Exploratory Trial (TESLA Trial)
The study will investigate whether liver transplantation provides increased survival, low side effects and good quality of life in patients with bile duct cancer where the tumor cannot be removed by normal surgery.
- Trial name
- NCT04556214
- Testing
- Liver Transplant
- Where
- Norway
- Volunteers
- 15 people
- Sponsor
- Oslo University Hospital
Liver Transplant, Kidney Transplant
A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant
The purpose of this study is to evaluate the impact of Advagraf, prolonged-release, once daily tacrolimus formulation, on long-term graft survival in kidney and liver allograft recipients.
- Trial name
- ADDRESS (NCT02057484)
- Testing
- Tacrolimus
- Where
- 145 sites in Austria, Belarus and 22 more
- Volunteers
- 2,300 people
- Sponsor
- Astellas Pharma Europe Ltd.
Liver Transplantation
Long-term Follow-up of Living Liver Donors: A Single-center Experience
Data on the long-term consequences of living liver donation are scarce. This study examined clinical, laboratory, and radiological parameters and long-term health-related quality of life (HRQoL) in 237 living liver donors and 239…
- Trial name
- NCT04814290
- Testing
- health-related quality of life (HRQoL) (36-item short-form health survey, version 1 [SF-36]).
- Volunteers
- 476 people
- Sponsor
- Mansoura University
Acute Kidney Injury, Liver Disease
Continuous Renal Replacement Therapy in the Setting of Orthotopic Liver Transplant
To evaluate the efficacy of continuous renal replacement therapy (CRRT) during orthotopic liver transplantation (OLT) in clearing excess solutes and improving acid-base parameters.
- Conditions
- Acute Kidney Injury, Liver Disease, Chronic Kidney Disease, End Stage Kidney Disease
- Trial name
- NCT01619449
- Testing
- Renal replacement therapy
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- University of Chicago
Liver Transplantation
Viability Testing and Transplantation of Marginal Livers
This study is designed to determine if a rejected liver is viable using normothermic machine liver perfusion (NMLP). It aims to 1.
- Trial name
- VITTAL (NCT02740608)
- Testing
- OrganOx metra
- Where
- United Kingdom
- Volunteers
- 22 people
- Sponsor
- University of Birmingham
Terlipressin Adverse Reaction, Liver Transplantation
Effect of Terlipressin on Cerebral Oxygen Saturation During Liver Transplantation
in our study the investigators aim to assess the effect of terlipressin on cerebral oxygenation monitored by cerebral oxymetry and cerebral blood flow measured by transcranial doppler.
- Trial name
- NCT03395574
- Testing
- Terlipressin, Normal saline
- Where
- Egypt
- Volunteers
- 30 people
- Sponsor
- Kasr El Aini Hospital
Hepatitis B
Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients
HepaGam B Hepatitis B Immune Globulin (HBIG) solution contains 10% maltose, which could possibly interfere with the measurement of glucose levels when using glucose non-specific tests.
- Trial name
- NCT00998426
- Testing
- glucose monitoring before and after HepaGam B administration, HepaGam B (Hepatitis B Immune Globulin (HBIG))
- Where
- United States
- Volunteers
- 5 people
- Sponsor
- Georgetown University
Postperfusion Syndrome
Reperfusion Syndrome and Vasoplegic Syndrome in Liver Transplant Surgery
The incidence of postreperfusion syndrome (PRS) and vasoplegic syndrome (VS) is unknown, and occasionally can be confused since these syndromes share some hemodynamic characteristics.
- Trial name
- NCT05658120
- Testing
- noradrenaline/adrenaline
- Where
- Spain
- Volunteers
- 246 people
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute
Liver Transplantation, Hepatocellular Carcinoma (HCC)
Survival and Recurrence After ABO-Incompatible Living Donor Liver Transplantation for Hepatocellular Carcinoma
This retrospective cohort study aimed to evaluate long-term oncologic outcomes after ABO-incompatible living donor liver transplantation (LDLT) for hepatocellular carcinoma (HCC).
- Trial name
- HCC (NCT07703735)
- Volunteers
- 371 people
- Sponsor
- Seoung Hoon Kim
Liver Transplant
Outflow Reconstruction in Right Lobe Living Donor Liver Transplantation
Modified Right Lobe Graft(MRLG) is one of the most common used graft in liver transplantation .Anterior sector of allograft in MRLG usually congested to decrease this congestion tributaries of middle hepatic vein should be…
- Trial name
- NCT03666689
- Testing
- surgical technique
- Volunteers
- 50 people
- Sponsor
- Assiut University
Newly Registered Patients for Primary Liver Transplantation
Effects of Preoperative Long-Term Immunonutrition in Patients Listed for Liver Transplantation
Patients with endstage liver disease characteristically are malnourished which is associated with poor outcome. Formulas enriched with arginine,ω3 fatty acids, and nucleotides potentially improve their nutritional status.
- Trial name
- PROUD (NCT00495859)
- Testing
- Immunonutrition, food for special medical purposes (FSMP)
- Where
- Germany
- Volunteers
- 156 people
- Sponsor
- Heidelberg University
Liver Transplant; Complications
Brain Protection Effect of Selective Head Cooling and Dexmedetomidine in Patients Undergoing Liver Transplantation
The investigators investigated in the present study whether selective head cooling and dexmedetomidine has an effect on cerebral oxygenation during liver transplantation and has cerebral protective effect in patients undergoing…
- Trial name
- NCT03102359
- Testing
- Dexmedetomidine, Cooling Helmet
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Huazhong University of Science and Technology
Colorectal Cancer, Liver Metastases
Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases
Patients with unresectable liver metastases (LM) from colorectal cancer (CRC)have a poor prognosis. In patients with resectable disease, surgery offers a distinct survival benefit.
- Trial name
- NCT02864485
- Testing
- live donor liver transplantation
- Where
- Canada
- Volunteers
- 20 people
- Sponsor
- University Health Network, Toronto
End Stage Liver Disease
Pilot Trial of Eculizumab Therapy to Reduce Preservation Injury in Human Macrosteatotic Liver Transplantation
The number of liver transplants that can be performed is limited by the availability of organs. Livers that are steatotic (i.e., infiltrated by triglycerides and other fatty substances) are usually not used for transplants, due…
- Trial name
- NCT03468140
- Testing
- Eculizumab, No intervention
- Where
- United States
- Sponsor
- Yale University
Myocardial Perfusion Imaging, Liver Failure
Myocardial Perfusion Imaging in Liver Transplantation Candidates
The optimal screening strategy for assessment of coronary artery disease in patients with end-stage liver disease (ESLD) is unclear.
- Trial name
- ExSPECT (NCT03864497)
- Testing
- Myocardial perfusion imaging
- Volunteers
- 403 people
- Sponsor
- University Hospital Birmingham NHS Foundation Trust
Acute-On-Chronic Liver Failure
Use of HA 330-II for Hemofiltration in Patients With ALF as a Bridge to Liver Transplantation .
ALF (ALF) is defined by three criteria: (1) rapid development of hepatocellular dysfunction (jaundice, coagulopathy), (2) hepatic encephalopathy, and (3) absence of a prior history of liver disease.
- Trial name
- NCT04243655
- Testing
- HA 330-II, Standard medical treatment (SMT)
- Where
- India
- Volunteers
- 10 people
- Sponsor
- Asian Institute of Gastroenterology, India
Cirrhosis, Liver
Comparison of the Effect of Two Interventions on Liver Frailty Index in Pre-frail and Frail Cirrhotic Patients Enlisted for Liver Transplantation
The goal of this prospective, double blind randomized clinical trial is to compare the effectiveness of two interventions in improve frailty (measured by Liver Frailty Index) and quality of life (measured by Chronic Liver Disease…
- Trial name
- NCT06149026
- Testing
- Physical and nutritional therapy
- Where
- Chile
- Volunteers
- 80 people
- Sponsor
- Pontificia Universidad Catolica de Chile
Hepatocellular Carcinoma, Cirrhosis
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
Immunotherapy can safely downstage patients and achieve durable systemic disease control to improve clinical outcomes in HCC patients undergoing liver transplant.
- Conditions
- Hepatocellular Carcinoma, Cirrhosis, Portal Hypertension
- Trial name
- NCT05027425
- Testing
- Durvalumab, Tremelimumab, Liver Transplant
- Where
- 3 sites in United States
- Volunteers
- 8 people
- Sponsor
- University of Cincinnati
Liver Graft Dysfunction
Utility of Combined EUS and ERCP Procedures in the Evaluation of Liver Graft Dysfunction
The purpose of this investigator-initiated study is to determine whether a single-step session that combines endoscopic ultrasound (which may further include liver biopsy and needle-guided cholangiography) with endoscopic…
- Trial name
- NCT04841278
- Testing
- EUS/ERCP
- Sponsor
- Loma Linda University
Hepatocellular Carcinoma, Scirrhous, Recurrence Tumor
HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular Carcinoma
Liver transplant is the most effective treatment for hepatocellular carcinoma (HCC) in cirrhosis. Due to organs shortage, the proper selection of patients is imperative.
- Trial name
- HepatoPredict (NCT04499833)
- Testing
- liver transplant
- Where
- Portugal
- Volunteers
- 40 people
- Sponsor
- Centro Hospitalar de Lisboa Central
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.